Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Peanut Allergy

Arkansas Children’s Research Institute 18-year Research Journey Pays off with Approval of First Peanut Allergy Drug

The Arkansas Children’s Research Institute, located on the campus of Arkansas Children’s Hospital, spent 18 years working on the drug Palforzia, […]

Arkansas Children’s Research Institute 18-year Research Journey Pays off with Approval of First Peanut Allergy Drug
1 year ago
Share

Dr. Stacie M. Jones Pursues Clinical and Translational Investigation of Food Allergies

Stacie M. Jones, M.D., is Professor and Chief of Allergy and Immunology at the University of Arkansas for Medical Sciences […]

Dr. Stacie M. Jones Pursues Clinical and Translational Investigation of Food Allergies
1 year ago
Share

Aimmune Receives FDA Approval for Palforzia; the First Treatment for Peanut Allergy

Aimmune announced the U.S. FDA has approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp], making this the first approved treatment for […]

Aimmune Receives FDA Approval for Palforzia; the First Treatment for Peanut Allergy
1 year ago
Share

FDA Approves First Drug Treatment of Peanut Allergy for Children

The U.S. Food and Drug Administration approved Aimmune Therapeutics’ Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, that may […]

FDA Approves First Drug Treatment of Peanut Allergy for Children
1 year ago
Share

Peanut Allergy Therapy – Millions for Peanuts

Analysts have put the cost at $4,200 a year

1 year ago
Share

Oral Immunotherapy Shown to Be Safe For Children With Peanut Allergies

In an issue of The Journal of Allergy and Clinical Immunology, a study was published that proved regular oral immunotherapy […]

2 years ago
Share

Aimmune’s Peanut Allergy Immunotherapy Meets Endpoints in Phase 3 ARTEMIS Trial

Aimmune Therapeutics announced the phase 3 European clinical trial of AR101 for the treatment of peanut allergy, known as ARTEMIS […]

2 years ago
Share

Peanut Allergy Clinical Trial Holds Hope for Kids

Kate Stromquist writing in the Northwest Arkansas Democrat Gazette reports on the local hope a global clinical trial brings to […]

2 years ago
Share

Aimmune Therapeutics Makes Experimental Product to Help Reduce Peanut Allergy Symptoms

BACKGROUND Peanut allergy, for which there are no approved treatment options, affects patients who are at risk for unpredictable and […]

2 years ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.